Lung Neuroendocrine Neoplasm clinical trials at UCSF
2 in progress, 1 open to eligible people
Lung neuroendocrine neoplasms are tumors that develop in the lung tissue. At UCSF, researchers are testing lutetium Lu 177 dotatate in patients whose tumors have special receptors. This study compares the effects of this treatment to the usual treatments available.
Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors
open to eligible people ages 18 years and up
This phase II trial studies the effect of lutetium Lu 177 dotatate compared to the usual treatment (everolimus) in treating patients with somatostatin receptor positive bronchial neuroendocrine tumors that have spread to other places in the body…
San Francisco, California and other locations
Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors
Sorry, in progress, not accepting new patients
This phase III trial studies cabozantinib to see how well it works compared with placebo in treating patients with neuroendocrine or carcinoid tumors that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of …
San Francisco, California and other locations
Our lead scientists for Lung Neuroendocrine Neoplasm research studies include Claire Mulvey.
Last updated: